跳至主要内容
临床试验/ACTRN12618001593224
ACTRN12618001593224已完成未知

Feasibility of the Cochlear™ Nucleus® Cochlear Implant in a Newly Implanted Adult Population.

Cochlear Ltd0 个研究点目标入组 10 人开始时间: 2018年9月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
Cochlear Ltd
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. A bilateral or unilateral moderately severe to profound postlinguistic sensorineural hearing loss and who have compromised functional hearing with hearing aids or receive no benefit with hearing aids.
  • 2. Fluent speaker in the local language used to assess clinical performance as judged by the investigator.
  • 3. Eighteen years of age or older at the time of enrolment with no upper age limit.
  • 4. A 30 day trial and/or experience with appropriately fit hearing aids.

排除标准

  • 1. Deafness due to lesions of the acoustic nerve or central auditory pathway.
  • 2. Active middle-ear infections.
  • 3. Tympanic membrane perforation.
  • 4. Ossification, malformation or any other cochlear anomaly, such as common cavity, that might prevent complete insertion of the electrode array, as confirmed by medical examination.
  • 5. Evidence of severe-to-profound hearing loss prior to 5 years of age.
  • 6. Pre-existing cochlear or bone conduction implant.
  • 7. Medical or psychological conditions that contraindicate general anaesthesia or surgery.
  • 8. Additional disabilities that may affect the subject’s participation or safety during the clinical investigation.
  • 9. Unrealistic expectations on the part of the subject, regarding the possible benefits, risks, and limitations that are inherent to the surgical procedure(s) and prosthetic devices as determined by the Investigator.
  • 10. Unwillingness or inability of the candidate to comply with all investigational requirements as determined by the Investigator.
  • 11. Existing CSF shunts or drains, existing perilymph fistula, skull fracture or CSF leaks
  • 12. Recurrent episodes of bacterial meningitis.
  • 13. Pre-existing skin condition that could jeopardize wound healing as judged by the investigator e.g. psoriasis, dermatitis, use of corticosteroids, uncontrolled diabetes.
  • 14. Pre-existing medical condition that requires serial MRI and CT.
  • 15. Pre-existing medical condition of peripheral neuropathy.

研究者

发起方
Cochlear Ltd

相似试验